- Home
- GV vs IMNN Comparison
GV vs IMNN Comparison
Compare GV & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- IMNN
- Stock Information
- Founded
- GV 2013
- IMNN 1982
- Country
- GV Canada
- IMNN United States
- Employees
- GV N/A
- IMNN N/A
- Industry
- GV Other Consumer Services
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- IMNN Health Care
- Exchange
- GV Nasdaq
- IMNN Nasdaq
- Market Cap
- GV 7.8M
- IMNN 12.1M
- IPO Year
- GV 2022
- IMNN 1985
- Fundamental
- Price
- GV $1.70
- IMNN $0.56
- Analyst Decision
- GV
- IMNN Buy
- Analyst Count
- GV 0
- IMNN 2
- Target Price
- GV N/A
- IMNN $14.00
- AVG Volume (30 Days)
- GV 67.1K
- IMNN 3.8M
- Earning Date
- GV 08-14-2025
- IMNN 08-13-2025
- Dividend Yield
- GV N/A
- IMNN N/A
- EPS Growth
- GV N/A
- IMNN N/A
- EPS
- GV N/A
- IMNN N/A
- Revenue
- GV $7,773,905.00
- IMNN N/A
- Revenue This Year
- GV N/A
- IMNN N/A
- Revenue Next Year
- GV N/A
- IMNN N/A
- P/E Ratio
- GV N/A
- IMNN N/A
- Revenue Growth
- GV N/A
- IMNN N/A
- 52 Week Low
- GV $1.00
- IMNN $0.37
- 52 Week High
- GV $9.60
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- GV 44.58
- IMNN 38.57
- Support Level
- GV $1.67
- IMNN $0.48
- Resistance Level
- GV $1.80
- IMNN $0.80
- Average True Range (ATR)
- GV 0.16
- IMNN 0.08
- MACD
- GV 0.01
- IMNN -0.01
- Stochastic Oscillator
- GV 48.36
- IMNN 29.00
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).